News and Announcements
Zagga Launches Mortgage-Backed Investment Opportunity with Full Licences & Average Returns of 9.75%
- Published July 12, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Zagga launches a mortgage-backed investment opportunity in Australia with full licences and averages 9.75% p.a net return to investors.
As a fully-licensed, secured marketplace lender, Zagga provides a transparent platform to algorithmically link wholesale/sophisticated investors with creditworthy borrowers. All loans are secured by real property.
During FY17, Zagga had many achievements which included:
- Obtaining both an Australian Credit Licence and an Australian Financial Services Licence in its own name.
- Launching on 28 June 2017 with many positive media mentions across Fintech Business, SMSF Magazine, Financial Standard and Digital Finance Analytics.
- Fully-funded two loan opportunities through the platform within the first week of launch, totalling $8.1M and returning an average of 9.75% p.a net to investors.
ABOUT ZAGGA
Zagga is your secured alternative. We offer an alternative investment within a diversified investment portfolio, with the potential of attractive returns within manageable risk parameters.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
